IPO registrations (S-1, F-1) · Registrants
Adynxx, Inc.
- SEC CIK
- 1054274 · filings on EDGAR ↗
- Former names
- Alliqua BioMedical, Inc. (2014–2019); Alliqua, Inc. (2010–2014); HEPALIFE TECHNOLOGIES INC (2003–2010); ZETA CORP (2003–2003); ZETA CORP /CA (2000–2003)
- Registration
- Form S-1, first filed 2005-08-18, last 2019-11-14; 6 initial registrations, 9 amendments
- Outcome
- Declared effective 2007-06-29; withdrawal requested 2005-12-13
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 100 PINE ST., STE. 500, San Francisco, CA 94111
- EIN
- 58-2349413
- EDGAR entity type
- operating
- Insiders and CEO pay
- Adynxx, Inc. on the corporate pages
Offering terms
- Shares offered
- 11,375,000
- Listing
- OTCQB under the symbol ADYX
- Lead underwriters
- H.C. Wainwright
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ALLIQUA BIOMEDICAL, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: ALLIQUA, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: ALLIQUA BIOMEDICAL, INC. EXACT (EIN (EXACT))
- Form D issuer: Alliqua BioMedical, Inc. EXACT (CIK (EXACT))
- SEC filer: Adynxx, Inc. EXACT (CIK (EXACT))
- Person page: Joseph M Leone Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 24
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2005-08-18 | S-1 | S-1 (registration) | HEPALIFE TECHNOLOGIES INC | 0001054274-05-000020 ↗ |
| 2005-11-04 | S-1/A | S-1/A (amendment) | HEPALIFE TECHNOLOGIES INC | 0001054274-05-000024 ↗ |
| 2005-12-13 | RW | RW (withdrawal request) | HEPALIFE TECHNOLOGIES INC | 0001054274-05-000028 ↗ |
| 2005-12-16 | S-1 | S-1 (registration) | HEPALIFE TECHNOLOGIES INC | 0001054274-05-000029 ↗ |
| 2006-01-13 | RW | RW (withdrawal request) | HEPALIFE TECHNOLOGIES INC | 0001054274-06-000001 ↗ |
| 2006-01-24 | S-1 | S-1 (registration) | HEPALIFE TECHNOLOGIES INC | 0001054274-06-000002 ↗ |
| 2006-02-09 | S-1/A | S-1/A (amendment) | HEPALIFE TECHNOLOGIES INC | 0001054274-06-000010 ↗ |
| 2007-06-11 | S-1/A | S-1/A (amendment) | HEPALIFE TECHNOLOGIES INC | 0001054274-07-000019 ↗ |
| 2007-06-12 | S-1 | S-1 (registration) | HEPALIFE TECHNOLOGIES INC | 0001054274-07-000020 ↗ |
| 2007-06-29 | EFFECT | EFFECT (declared effective) | HEPALIFE TECHNOLOGIES INC | 9999999995-07-002615 ↗ |
| 2007-07-05 | EFFECT | EFFECT (declared effective) | HEPALIFE TECHNOLOGIES INC | 9999999995-07-002695 ↗ |
| 2009-07-08 | S-1 | S-1 (registration) | HEPALIFE TECHNOLOGIES INC | 0001054274-09-000007 ↗ |
| 2009-07-13 | S-1/A | S-1/A (amendment) | HEPALIFE TECHNOLOGIES INC | 0001054274-09-000009 ↗ |
| 2009-07-17 | EFFECT | EFFECT (declared effective) | HEPALIFE TECHNOLOGIES INC | 9999999995-09-001988 ↗ |
| 2009-11-24 | EFFECT | EFFECT (declared effective) | HEPALIFE TECHNOLOGIES INC | 9999999995-09-003279 ↗ |
| 2014-09-25 | EFFECT | EFFECT (declared effective) | Alliqua BioMedical, Inc. | 9999999995-14-002871 ↗ |
| 2015-04-20 | EFFECT | EFFECT (declared effective) | Alliqua BioMedical, Inc. | 9999999995-15-000926 ↗ |
| 2019-06-17 | S-1 | S-1 (registration) | Adynxx, Inc. | 0001144204-19-031211 ↗ |
| 2019-07-25 | S-1/A | S-1/A (amendment) | Adynxx, Inc. | 0001144204-19-035849 ↗ |
| 2019-08-22 | S-1/A | S-1/A (amendment) | Adynxx, Inc. | 0001144204-19-041009 ↗ |
| 2019-10-11 | S-1/A | S-1/A (amendment) | Adynxx, Inc. | 0001144204-19-048109 ↗ |
| 2019-11-08 | S-1/A | S-1/A (amendment) | Adynxx, Inc. | 0001104659-19-061704 ↗ |
| 2019-11-14 | S-1/A | S-1/A (amendment) | Adynxx, Inc. | 0001104659-19-063666 ↗ |
| 2020-03-20 | RW | RW (withdrawal request) | Adynxx, Inc. | 0001104659-20-036845 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-11-14 | S-1/A | registration statement | 11,375,000 | - | OTCQB ADYX | 1 | primary document; shares headline, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| RAYAT HARMEL S | Director,Officer; Director,Officer,TenPercentOwner | President/CEO; Secretary/Treasurer; SECRETARY/TREASURER; SECRETARY, TREASURER, CFO | 4 | 2006–2008 | |
| Menzler Frank | Director,Officer | President and CEO; PRESIDENT AND CEO; PRESIDENT/CEO | 3 | 2006–2008 | |
| Jimenez Javier | Director | 2 | 2007–2008 | ||
| SCHOMER ROLAND | Director | 2 | 2008–2009 | ||
| BHOGAL JATINDER S | Director | 1 | 2008 | ||
| SIERCHIO JOSEPH | Director | 4 | 2008–2012 | ||
| BERGER STEVEN C | Officer | CFO, Treasurer and Secretary | 6 | 2010–2013 | |
| HARBORVIEW MASTER FUND LP | Other; TenPercentOwner | -; Chairman | 18 | 2010–2012 | |
| ROSENBLUM RICHARD | Director; Director,Officer,TenPercentOwner; Director,TenPercentOwner; Officer,TenPercentOwner; Other; TenPercentOwner | -; Chairman; President | 23 | 2010–2014 | |
| STEFANSKY DAVID | Director; Director,Officer,TenPercentOwner; Director,TenPercentOwner; Other; TenPercentOwner | -; Chairman | 23 | 2010–2014 | |
| Harborview Advisors, LLC | Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner; TenPercentOwner | -; Managing Member; President | 20 | 2011–2013 | |
| Harborview Value Master Fund, L.P. | Director,Officer,TenPercentOwner; Other; TenPercentOwner | -; President | 21 | 2011–2013 | |
| GOLDBERG MICHAEL M | Director | 4 | 2011–2012 | ||
| LEONE JOSEPH M | Director | 14 | 2011–2017 | person page Fuzzy | |
| Pearsen Kenneth D. | Director | 6 | 2011–2014 | ||
| Sklar Jeffrey | Director | 11 | 2011–2017 | ||
| STEIN NACHUM | Director | 4 | 2011–2012 | ||
| 1420525 ALBERTA LTD. | TenPercentOwner | 2 | 2011–2012 | ||
| Harborview Capital Management, LLC | Director,TenPercentOwner; Other; TenPercentOwner | 13 | 2011–2013 | ||
| Frost Gamma Investments Trust | TenPercentOwner | 1 | 2012 | ||
| LONDONER KENNETH L | Director | 6 | 2012–2014 | ||
| ZELDIS JEROME B | Director | 17 | 2012–2017 | ||
| SAPIRSTEIN JAMES | Director,Officer; Officer | CEO, Alliqua Biomedical, Inc.; CEO, Therapeutics Division; Chief Executive Officer | 4 | 2012–2014 | |
| Johnson David Ian | Director; Director,Officer; Officer | President and CEO | 24 | 2012–2017 | |
| POSNER BRIAN M | Officer | Chief Financial Officer | 15 | 2013–2017 | |
| CELGENE CORP /DE/ | TenPercentOwner | 5 | 2013–2017 | ||
| KARSEN PERRY A | Director | 1 | 2013 | ||
| AFRICK ANDREW | Director | 3 | 2014–2015 | ||
| RESTANI GARY C | Director | 5 | 2014–2017 | ||
| BARTON BRADFORD | Officer | Chief Operating Officer | 11 | 2014–2017 | |
| WAGNER MARK T | Director | 7 | 2015–2017 | ||
| Pionati Pellegrino | Officer | Chief Strategy & Marketing Off; See Remarks | 10 | 2015–2017 | |
| Kung Winston | Director | 1 | 2016 | ||
| Warusz Joseph Michael | Officer | Chief Financial Officer | 1 | 2018 | |
| ABEL STAN E | Director | 2 | 2019 | ||
| Legault Pierre | Director | 1 | 2019 | ||
| MAMET JULIEN | Director,Officer | CHIEF SCIENTIFIC OFFICER | 2 | 2019 | |
| Manning Donald C. | Officer | CHIEF MEDICAL OFFICER | 2 | 2019 | |
| ORR RICK | Director,Officer | CHIEF EXECUTIVE OFFICER | 2 | 2019 | |
| Podlesak Dennis | Director | 2 | 2019 | ||
| RUTH MATTHEW | Director | 1 | 2019 | ||
| WEBER ECKARD | Director | 2 | 2019 | ||
| BLAIR JAMES C | TenPercentOwner | 2 | 2019 | ||
| BONDERMAN DAVID | TenPercentOwner | 1 | 2019 | ||
| COULTER JAMES G | TenPercentOwner | 1 | 2019 | ||
| Domain Partners VIII, L.P. | TenPercentOwner | 1 | 2019 | ||
| DOVEY BRIAN H | TenPercentOwner | 2 | 2019 | ||
| DP VIII Associates, L.P. | TenPercentOwner | 1 | 2019 | ||
| Halak Brian K | TenPercentOwner | 2 | 2019 | ||
| TPG Group Holdings (SBS) Advisors, Inc. | TenPercentOwner | 1 | 2019 | ||
| TREU JESSE I | TenPercentOwner | 2 | 2019 | ||
| VITULLO NICOLE | TenPercentOwner | 2 | 2019 | ||
| GONZALEZ DINA | Officer | CONTROLLER | 1 | 2019 | |
| FLESHER GREGORY J. | Director | 1 | 2019 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-03-13 | Alliqua BioMedical, Inc. | Biotechnology | $2,900,000 | $2,770,000 | 8 | 1 |
| 2014-05-15 | Alliqua, Inc. | Biotechnology | $7,003,080 | $2,003,080 | 43 | 1 |
| 2014-04-28 | Alliqua, Inc. | Biotechnology | $14,975,000 | $14,975,000 | 18 | 1 |
| 2012-03-01 | Alliqua, Inc. | Biotechnology | $1,050,000 | $1,050,000 | 12 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ALLIQUA BIOMEDICAL, INC. | PA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | ALLIQUA, INC. | PA | State business registries | EIN (EXACT, as the state registration reports it) |
| Form D issuer | Alliqua BioMedical, Inc. | PA | Form D private offerings | CIK (EXACT) |
| SEC filer | Adynxx, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | ALLIQUA BIOMEDICAL, INC. | EIN (EXACT) | ||
| Form D issuer | ADYNXX, INC. | Form D private offerings | name and state | |
| Person page | Joseph M Leone | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, CA first:
- FUSION MEDICAL TECHNOLOGIES INC CA
- ENDOLOGIX INC /DE/ CA
- CEMAX ICON INC CA
- TRYLON CORP CA
- R2 TECHNOLOGY INC CA
- CERUS CORP CA
- SOMNUS MEDICAL TECHNOLOGIES INC CA
- MICRUS ENDOVASCULAR CORP CA
- AEROGEN INC CA
- IOMED LLC CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology